Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by IncoproHosted by Managing IP’s Ed Conlon, the discussion at Incopro’s Insync Virtual Summit explored how the pandemic has affected brand protection teams and offered key insights to drive success in 2021 -
Sponsored by Januar Jahja & PartnersAndrew Diamond and Fabiola Rossy of Januar Jahja and Partners take a closer look at the recent trademark battle between two large oral care brands
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners looks at a recent judicial decision concerning the Antimonopoly Act and considers the growing litigation of this area in Japan
-
Sponsored by AnJie Law FirmLi Wu of AnJie Law Firm explains how the administrative and judicial sectors are slowly embracing a more favourable stance towards the acceptance of post-filing supplementary data
-
Sponsored by Griffith HackRobert Wulff and Arun Nagasubramanian of Griffith Hack analyse patent filings statistics to assess Australian and global progress towards building a hydrogen-fuelled economy
-
Sponsored by Bird & BirdRichard Vary of Bird & Bird explains why Wuhan has become a destination jurisdiction of anti-suit injunctions and looks at the challenges that implementers face
